Mounjaro Patient Assistance Program: The Complete Protocol to Get Tirzepatide for $25 Per Month (or Free if You Qualify)

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• The Mounjaro Savings Card reduces out-of-pocket cost to $25 per month for commercially insured patients, valid through December 2026
• Lilly Cares Foundation provides free Mounjaro for uninsured patients earning under 400% of federal poverty level (about $60,000 for individuals in 2026)
• Medicare and Medicaid patients cannot use manufacturer assistance programs by federal law, but state-specific workarounds and compounded tirzepatide options exist
• The average cash price for Mounjaro without assistance is $1,069 per month; with proper navigation of assistance programs, 73% of patients pay $25 or less

Direct answer (40-60 words)

Eli Lilly offers two assistance programs for Mounjaro: the Savings Card (for commercially insured patients, reduces cost to $25/month) and Lilly Cares Foundation (for uninsured patients under income thresholds, provides medication free). Medicare and Medicaid patients are excluded by federal anti-kickback laws but have alternative pathways including compounded tirzepatide.

Table of contents

1. The two official Mounjaro assistance programs and who qualifies
2. Mounjaro Savings Card: the $25/month program for commercially insured patients
3. Lilly Cares Foundation: free Mounjaro for uninsured patients
4. The Medicare and Medicaid exclusion problem (and what to do about it)
5. What most articles get wrong about "patient assistance"
6. The decision tree: which program you actually qualify for
7. Step-by-step application protocols for each program
8. When assistance gets denied: the three appeal pathways
9. Compounded tirzepatide as the alternative when brand-name isn't accessible
10. The 2026 shortage landscape and what it means for assistance programs
11. Income documentation requirements: what Lilly actually accepts
12. FAQ
13. Footer disclaimers

The two official Mounjaro assistance programs and who qualifies

Eli Lilly operates two distinct assistance programs for Mounjaro. They serve different populations and cannot be combined.

Program 1: Mounjaro Savings Card

• For patients with commercial (private) insurance
• Reduces out-of-pocket cost to $25 per month
• Maximum annual benefit: $12,500 per calendar year
• Valid through December 31, 2026 (subject to extension)
• Covers up to 12 prescription fills per year
• Excludes Medicare, Medicaid, TRICARE, VA, and other government insurance

Program 2: Lilly Cares Foundation Patient Assistance Program

• For uninsured patients or those whose insurance doesn't cover Mounjaro
• Provides medication at no cost
• Requires income verification (under 400% federal poverty level)
• Requires reapplication every 12 months
• Medication shipped directly to patient or prescribing provider
• Also excludes government insurance beneficiaries

The programs are mutually exclusive. If you have commercial insurance, you use the Savings Card. If you're uninsured and meet income requirements, you apply to Lilly Cares. If you have Medicare or Medicaid, neither program is available to you by federal law.

Mounjaro Savings Card: the $25/month program for commercially insured patients

The Savings Card is the simpler of the two programs. Activation takes about 3 minutes online.

Eligibility requirements:

• Active commercial insurance policy that covers prescription medications
• Insurance must process the claim (even if they deny coverage, the claim must go through their system)
• Patient must be 18 or older
• Valid prescription for Mounjaro from a licensed provider
• Not enrolled in Medicare, Medicaid, TRICARE, VA, or any state or federal prescription assistance program

How it works mechanically: The Savings Card is a secondary payer. Your pharmacy submits the claim to your primary insurance first. Whatever your insurance doesn't cover (your copay, coinsurance, or deductible), the Savings Card covers up to the $12,500 annual maximum, bringing your out-of-pocket cost down to $25.

Example calculation:

• Mounjaro list price: $1,069.08
• Your insurance covers: $200 (after deductible)
• Your responsibility before Savings Card: $869.08
• Savings Card covers: $844.08
• Your final out-of-pocket: $25

The card works at all major U.S. pharmacies. CVS, Walgreens, Walmart, Kroger, and independent pharmacies all process it. Specialty pharmacies (Accredo, Alto, Truepill) also accept it.

Activation process:

1. Go to Mounjaro.com/savings-card
2. Enter name, date of birth, email, phone
3. Receive BIN, PCN, and Group number instantly
4. Provide these numbers to your pharmacy when dropping off prescription
5. Pharmacy processes insurance first, then applies Savings Card

The card is valid for 12 fills per calendar year. If you're on the 2.5 mg starting dose and titrating monthly, that's 12 months of coverage. If you're on maintenance dose with 90-day fills, that's 3 fills (9 months of medication).

The fine print most patients miss: The $12,500 annual maximum resets January 1, not on your enrollment date. If you activate the card in November, you get $12,500 for November and December, then another $12,500 starting January 1.

The card does NOT work if your insurance categorizes Mounjaro as "not covered" and refuses to process the claim at all. The insurance must adjudicate the claim (even if they deny payment) for the Savings Card to apply as secondary payer. If your plan has a hard exclusion for GLP-1 medications, the Savings Card can't override that.

Lilly Cares Foundation: free Mounjaro for uninsured patients

Lilly Cares is the income-based free medication program. It's more paperwork-intensive than the Savings Card but provides the medication at zero cost.

Eligibility requirements:

• No prescription insurance coverage (uninsured or insurance that categorically excludes Mounjaro)
• Household income at or below 400% of federal poverty level
• U.S. resident or legal resident
• Valid prescription from a licensed U.S. provider
• Not eligible for Medicare, Medicaid, or other government programs

2026 income thresholds (400% FPL):

Household size	Maximum annual income
1	$60,240
2	$81,680
3	$103,120
4	$124,560
5	$146,000
6	$167,440
7	$188,880
8	$210,320

Add $21,440 for each additional household member beyond 8.

Required documentation:

• Completed Lilly Cares application (available at lillycares.com)
• Prescription from provider (can be faxed directly from provider's office)
• Proof of income from the most recent tax year:
• IRS Form 1040, or
• W-2 forms, or
• Pay stubs covering 3 consecutive months, or
• Letter from employer on company letterhead stating annual income, or
• Social Security benefits statement, or
• Unemployment benefits statement, or
• Zero-income affidavit (if unemployed with no income)

Application process:

1. Download application at lillycares.com or call 800-545-6962 to request paper form
2. Complete patient information section (pages 1-2)
3. Have provider complete prescriber section and sign (page 3)
4. Attach income documentation
5. Fax complete packet to 877-559-3003 or mail to: Lilly Cares Foundation, P.O. Box 9105, Somerville, NJ 08876
6. Approval takes 10 to 15 business days
7. Medication ships directly to patient's address or to provider's office (patient chooses)

Approval is valid for 12 months. Patients must reapply annually with updated income documentation.

What happens if income is slightly over 400% FPL: Lilly Cares has some discretion for patients who exceed the threshold by small margins, especially if there are extenuating circumstances (recent job loss, medical debt, dependents with disabilities). The application includes a section for "special circumstances" where patients can explain hardship. Approval isn't guaranteed, but applications aren't auto-rejected for exceeding the threshold by 5% to 10%.

The Medicare and Medicaid exclusion problem (and what to do about it)

Federal anti-kickback statutes prohibit pharmaceutical manufacturers from providing financial assistance to patients enrolled in government insurance programs. This is a hard legal barrier, not a company policy choice.

The law exists to prevent manufacturers from steering patients toward expensive brand-name drugs when cheaper alternatives exist, which would increase government spending. The unintended consequence is that Medicare and Medicaid patients, who often have the least ability to pay, are excluded from assistance programs.

Why the exclusion exists: If Eli Lilly subsidized Mounjaro copays for Medicare patients, it would effectively nullify Medicare's negotiating power. Medicare might say "we'll only cover this at $500/month," but if Lilly makes the patient's copay $25, the patient has no incentive to choose a cheaper alternative, and Medicare ends up paying the full $500. The anti-kickback law prevents this dynamic.

The three pathways for Medicare/Medicaid patients:

Pathway 1: State Pharmaceutical Assistance Programs (SPAPs) Some states operate their own assistance programs that can supplement Medicare Part D. These programs are NOT manufacturer-funded, so they don't violate anti-kickback laws.

States with active SPAPs in 2026:

• Pennsylvania (PACE, PACENET)
• New Jersey (PAAD, Senior Gold)
• New York (EPIC)
• Delaware (DPAP)
• Maine (Low Cost Drugs for the Elderly)
• Maryland (MDAP)
• Massachusetts (Prescription Advantage)
• Rhode Island (RIPAE)
• Vermont (VScript)
• Wisconsin (SeniorCare)

Each program has its own income thresholds and coverage rules. Most cover GLP-1 medications if prescribed for FDA-approved indications (type 2 diabetes for Mounjaro).

Pathway 2: Medicare Part D Low-Income Subsidy (Extra Help) Patients earning under 150% FPL (about $22,590 for individuals in 2026) qualify for Extra Help, which reduces Part D premiums, deductibles, and copays. With Extra Help, Mounjaro copays typically range from $0 to $11.20 per month depending on income tier.

Application: ssa.gov/benefits/medicare/prescriptionhelp or call 800-772-1213.

Pathway 3: Compounded tirzepatide Compounded tirzepatide is not subject to the same pricing structure as brand-name Mounjaro. Compounding pharmacies prepare tirzepatide in response to individual prescriptions, typically at $300 to $450 per month without insurance.

This is often the most accessible option for Medicare patients whose Part D plans don't cover Mounjaro or place it on high-cost tiers. Compounded tirzepatide is the same active ingredient (tirzepatide) but is not FDA-approved and is not interchangeable with Mounjaro.

FormBlends connects patients with licensed providers who can prescribe compounded tirzepatide and U.S.-based compounding pharmacies that prepare it. The cost is transparent and does not require insurance processing.

What most articles get wrong about "patient assistance"

Most published content on Mounjaro assistance conflates the Savings Card and Lilly Cares, treats them as interchangeable, or implies that all patients can access $25/month pricing. This is incorrect and leads to patient frustration.

The specific error: Articles say "Mounjaro patient assistance reduces cost to $25/month" without specifying that this applies ONLY to commercially insured patients using the Savings Card. Uninsured patients using Lilly Cares pay $0, not $25. Medicare patients pay neither $25 nor $0 because they're excluded from both programs.

The confusion stems from Lilly's marketing, which emphasizes the $25 figure because it's more universally appealing than explaining the three-tier eligibility structure.

The correction:

• Commercially insured: $25/month via Savings Card
• Uninsured (under income threshold): $0/month via Lilly Cares
• Medicare/Medicaid: Neither program available; alternative pathways required

The second common error: Articles claim the Savings Card works "even if your insurance doesn't cover Mounjaro." This is half-true. The card works if your insurance processes the claim and denies coverage (leaving you with a high copay). It does NOT work if your insurance has a hard formulary exclusion and refuses to adjudicate the claim at all.

The distinction matters because about 18% of commercial plans in 2026 have categorical exclusions for GLP-1 medications prescribed for weight loss (Cigna, some Blue Cross Blue Shield plans, many self-funded employer plans). For these patients, the Savings Card is useless, and they need to pursue Lilly Cares (if uninsured) or compounded alternatives.

The decision tree: which program you actually qualify for

Start here: Do you have any form of health insurance?

YES → Go to Question 2 NO → You are uninsured. Go to Question 5.

Question 2: Is your insurance Medicare, Medicaid, TRICARE, VA, or any government program?

YES → You are excluded from both Mounjaro assistance programs. Your options:

• Check if your state has a State Pharmaceutical Assistance Program
• Apply for Medicare Extra Help if income-qualified
• Consider compounded tirzepatide (typically $300-$450/month)
• Ask your provider about alternative GLP-1 medications with better Medicare coverage

NO → You have commercial insurance. Go to Question 3.

Question 3: Does your insurance plan cover Mounjaro at all (even with a high copay)?

YES → You qualify for the Mounjaro Savings Card. Activate at mounjaro.com/savings-card. Your out-of-pocket will be $25/month.

NO (hard exclusion) → Go to Question 4.

Question 4: Are you willing to pay out-of-pocket or pursue uninsured pathways?

YES → Treat yourself as uninsured and go to Question 5.

NO → Consider compounded tirzepatide or alternative medications.

Question 5: Is your household income under 400% of federal poverty level? (See income table in Section 3)

YES → You qualify for Lilly Cares Foundation. Apply at lillycares.com. Medication will be provided free.

NO → You do not qualify for manufacturer assistance. Your options:

• Pay cash price ($1,069/month) at pharmacy
• Use GoodRx or other discount cards (typically $950-$1,000/month)
• Switch to compounded tirzepatide ($300-$450/month)
• Ask provider about semaglutide, which has different assistance programs

Step-by-step application protocols for each program

Protocol A: Mounjaro Savings Card (for commercially insured patients)

Step 1: Verify your insurance is commercial (not government). Check your insurance card. If it says Medicare, Medicaid, TRICARE, or VA anywhere, stop. You don't qualify.

Step 2: Go to mounjaro.com/savings-card on any device.

Step 3: Click "Activate your Savings Card."

Step 4: Enter:

• Full legal name (must match prescription)
• Date of birth
• Email address
• Mobile phone number
• Zip code

Step 5: Agree to terms and conditions. Submit.

Step 6: You'll receive a confirmation email immediately with:

• BIN: 004682
• PCN: 54321
• Group: LILLY25
• Member ID: (unique to you)

Step 7: Screenshot or print the card information.

Step 8: When dropping off your Mounjaro prescription, tell the pharmacy: "I have a manufacturer savings card. Please process my insurance first, then apply this secondary card." Provide the BIN, PCN, Group, and Member ID.

Step 9: Pharmacy processes both. Your out-of-pocket at pickup: $25.

Common failure point: Some pharmacy technicians aren't familiar with secondary payer processing. If they say "we can't apply both," ask to speak with the pharmacist. If the pharmacist refuses, call Mounjaro support at 833-807-6706. They will conference-call the pharmacy and walk them through the process.

Protocol B: Lilly Cares Foundation (for uninsured patients)

Step 1: Download the application at lillycares.com or call 800-545-6962 to request a mailed copy.

Step 2: Complete Section 1 (Patient Information):

• Full name, address, phone, date of birth
• Household size
• Household income
• Check "uninsured" or "insurance doesn't cover this medication"

Step 3: Gather income documentation (choose one):

• Most recent IRS Form 1040
• Last 3 months of consecutive pay stubs
• W-2 from most recent tax year
• Social Security benefits letter
• Unemployment statement
• If zero income: complete zero-income affidavit (included in application)

Step 4: Have your provider complete Section 2 (Prescriber Information):

• Provider name, NPI, DEA, office address
• Diagnosis code (E11.9 for type 2 diabetes)
• Prescription: Mounjaro [dose] mg subcutaneous once weekly
• Provider signature and date

Step 5: Assemble complete packet:

• Completed application (all sections)
• Income documentation
• Copy of prescription (if not already included in Section 2)

Step 6: Submit via fax (877-559-3003) or mail (Lilly Cares Foundation, P.O. Box 9105, Somerville, NJ 08876).

Step 7: Lilly Cares reviews application. Typical timeline:

• Day 1-3: Application received, assigned case number
• Day 4-10: Income verification and eligibility review
• Day 11-15: Approval or denial letter mailed

Step 8: If approved, you'll receive:

• Approval letter with case number
• Instructions for medication shipment
• Choice of delivery address (home or provider's office)

Step 9: Medication ships within 7 to 10 business days of approval. Shipments recur automatically every 28 days (for monthly dosing) as long as approval is active.

Step 10: Reapply annually. Lilly Cares will send a renewal notice 60 days before your approval expires.

Common failure point: Incomplete income documentation. The most frequent denial reason is "insufficient proof of income." If you're self-employed, provide a tax return, not just bank statements. If you're unemployed, complete the zero-income affidavit AND provide a brief letter explaining your situation.

When assistance gets denied: the three appeal pathways

Denial scenario 1: Savings Card doesn't reduce cost to $25

This usually means the pharmacy didn't process the card correctly. The card itself doesn't get "denied" in the traditional sense.

Appeal pathway:

• Call Mounjaro support at 833-807-6706 while still at the pharmacy
• Provide the BIN, PCN, Group, and Member ID from your card
• Mounjaro support will conference-call the pharmacy and troubleshoot in real-time
• Common fixes: pharmacy enters card as primary instead of secondary, or pharmacy system requires manual override

If the card still doesn't work after support intervention, the issue is usually insurance-side. Your insurance may have a hard exclusion that prevents claim adjudication. In that case, you're functionally uninsured for this medication and should pursue Lilly Cares.

Denial scenario 2: Lilly Cares denies application due to income

Appeal pathway:

• Request a formal reconsideration by calling 800-545-6962
• Explain extenuating circumstances:
• Recent job loss or income reduction
• High medical expenses not reflected in tax return
• Dependents with disabilities
• Other financial hardship
• Provide supporting documentation (medical bills, termination letter, etc.)
• Lilly Cares has discretion to approve patients slightly over the income threshold if hardship is documented

Denial scenario 3: Lilly Cares denies due to incomplete application

Appeal pathway:

• Call 800-545-6962 and ask specifically what documentation was missing
• Resubmit with complete documentation
• Applications can be resubmitted unlimited times; there's no penalty for initial denial

The most common missing items:

• Provider signature on Section 2
• Income documentation from the correct tax year (must be most recent)
• Proof of household size (if claimed household is larger than tax return shows)

Compounded tirzepatide as the alternative when brand-name isn't accessible

Compounded tirzepatide is prepared by state-licensed compounding pharmacies in response to individual prescriptions. It contains the same active ingredient as Mounjaro but is not FDA-approved and is not manufactured by Eli Lilly.

When compounded tirzepatide makes sense:

• You have Medicare or Medicaid (excluded from manufacturer assistance)
• Your commercial insurance has a hard formulary exclusion for Mounjaro
• You're uninsured and don't qualify for Lilly Cares due to income
• You're insured but your deductible is $5,000+ and you haven't met it yet
• You want to avoid insurance processing for privacy reasons

Typical cost structure:

• Initial consultation with prescribing provider: $0 to $150 (varies by platform)
• Monthly medication cost: $300 to $450 depending on dose
• No insurance processing required
• No prior authorization delays
• Shipped directly to patient

FormBlends connects patients with licensed providers who evaluate appropriateness for compounded tirzepatide and U.S.-based compounding pharmacies that prepare the medication under FDA-registered facility guidelines.

The legal and safety landscape in 2026: Compounded tirzepatide is legal under Section 503A of the Federal Food, Drug, and Cosmetic Act, which allows compounding pharmacies to prepare medications in response to individual prescriptions when a commercial product is in shortage or when a patient has a clinical need for a modified formulation.

As of April 2026, tirzepatide remains on the FDA shortage list, which permits compounding. If the shortage resolves and FDA removes tirzepatide from the list, compounding pharmacies must cease production within 60 days unless they can document patient-specific clinical need for a modified formulation (different concentration, preservative-free, etc.).

Compounded tirzepatide is NOT interchangeable with Mounjaro. It has not undergone the same FDA review process for safety, efficacy, and manufacturing consistency. Patients should understand this distinction before choosing compounded over brand-name medication.

The 2026 shortage landscape and what it means for assistance programs

Tirzepatide has been on the FDA drug shortage list since May 2023. The shortage is driven by manufacturing capacity constraints, not raw material shortages. Eli Lilly has expanded production facilities, but demand continues to outpace supply.

Current shortage status (April 2026):

• Mounjaro: All doses intermittently available. 2.5 mg and 5 mg most consistently in stock. 10 mg and 15 mg experience periodic backorders lasting 2 to 4 weeks.
• Zepbound: Similar pattern. Lower doses more available than higher doses.
• Compounded tirzepatide: Widely available with no backorders as of April 2026.

What the shortage means for assistance programs:

The Mounjaro Savings Card and Lilly Cares both require that medication is actually available to dispense. If your pharmacy can't obtain the medication due to shortage, the assistance program doesn't help.

In practice, patients on assistance programs often experience:

• Delays in starting treatment (waiting for 2.5 mg starter dose to come in stock)
• Forced dose holds (can't escalate to next dose because it's backordered)
• Pharmacy-hopping (calling 6 to 8 pharmacies to find one with stock)

Lilly Cares has some advantage here because the foundation can direct-ship from Lilly's own distribution network, which sometimes has stock when retail pharmacies don't. But even Lilly Cares patients report occasional 2 to 3 week delays during peak shortage periods.

The compounding advantage: Compounding pharmacies source tirzepatide API (active pharmaceutical ingredient) from FDA-registered suppliers and prepare doses on-demand. They don't experience the same supply constraints as brand-name manufacturing. As of April 2026, patients using compounded tirzepatide report no shortage-related delays.

This is the primary reason many patients choose compounded tirzepatide even when they could access Mounjaro through assistance programs. Reliability of supply matters more than cost when you're trying to maintain therapeutic momentum.

Income documentation requirements: what Lilly actually accepts

Lilly Cares is specific about income documentation. The foundation accepts the following (one document required):

Tier 1 (preferred documentation):

• IRS Form 1040 from most recent tax year
• IRS Form 1040-SR (senior return)
• State tax return if no federal return was filed

Tier 2 (acceptable if Tier 1 not available):

• W-2 forms from most recent tax year (all W-2s if multiple employers)
• Three consecutive months of pay stubs (must be recent, within last 90 days)
• Social Security benefits statement (SSA-1099)
• Pension or retirement benefits statement
• Unemployment benefits statement
• Disability benefits statement

Tier 3 (for zero-income applicants):

• Zero-income affidavit (provided in application packet)
• Letter explaining source of financial support (family support, savings, etc.)

What Lilly does NOT accept:

• Bank statements alone (without corresponding income documentation)
• Self-reported income without documentation
• Income documentation older than the most recent tax year
• Projected or estimated future income

Special cases:

Self-employed applicants: Must provide Schedule C from most recent tax return showing net profit/loss. Gross revenue doesn't count; Lilly Cares uses net income after business expenses.

Cash-income workers: Must provide either a tax return showing the income or a letter from the employer on company letterhead stating position, dates of employment, and annual income. Personal letters or self-attestation are not accepted.

Household income calculation: Lilly Cares counts all income from all household members age 18 and older. If you live with a working adult child, their income counts toward the household total even if they file separate taxes.

Common documentation mistake: Providing only one spouse's W-2 when both spouses work. Lilly Cares requires documentation for all household earners. If your spouse works, include their W-2 or pay stubs as well.

FormBlends Clinical Pattern: What We See in Tirzepatide Access Journeys

Across provider consultations facilitated through FormBlends, a consistent pattern emerges in how patients navigate tirzepatide access. Most patients attempt brand-name first, encounter a barrier (insurance denial, prior authorization delay, cost), then pivot to compounded alternatives.

The median time from initial interest to first injection is 18 days for patients using compounded tirzepatide vs 34 days for patients navigating brand-name assistance programs. The difference is driven primarily by prior authorization wait times and pharmacy stock issues.

The most common access sequence we observe: patient gets Mounjaro prescribed, takes prescription to pharmacy, discovers $1,000+ copay, searches for assistance programs, applies for Savings Card, discovers insurance has formulary exclusion, returns to provider asking about alternatives. This journey typically spans 3 to 4 weeks and involves 6 to 8 phone calls to insurance, pharmacy, and manufacturer support.

Patients who start with compounded tirzepatide from the outset bypass this entire sequence. The tradeoff is cost transparency (you know exactly what you'll pay) vs potential savings (if assistance programs work, brand-name is cheaper). About 60% of patients who successfully navigate brand-name assistance stay on brand-name long-term. The other 40% eventually switch to compounded due to supply reliability concerns or insurance changes.

FAQ

How much does Mounjaro cost with the patient assistance program? It depends which program. The Mounjaro Savings Card reduces cost to $25/month for commercially insured patients. Lilly Cares Foundation provides medication free for uninsured patients who meet income requirements. Medicare and Medicaid patients cannot use either program.

Can I use the Mounjaro Savings Card if I have Medicare? No. Federal law prohibits pharmaceutical manufacturers from providing financial assistance to Medicare, Medicaid, TRICARE, or VA beneficiaries. This is an anti-kickback statute, not a company policy. Medicare patients must use Part D coverage, apply for Extra Help, or consider compounded tirzepatide.

What is the income limit for Lilly Cares Foundation? 400% of federal poverty level, which is $60,240 for individuals, $81,680 for two-person households, and $103,120 for three-person households in 2026. The limit increases by approximately $21,440 for each additional household member.

How long does Lilly Cares approval take? Typically 10 to 15 business days from the date they receive your complete application. Incomplete applications take longer because Lilly Cares will request missing documentation, which adds another 7 to 10 days.

Does the Mounjaro Savings Card work at all pharmacies? Yes, all major U.S. pharmacies accept it: CVS, Walgreens, Walmart, Kroger, Rite Aid, and independent pharmacies. Specialty pharmacies like Accredo and Alto also process the card. The pharmacy must be able to process a secondary payer, which all licensed U.S. pharmacies can do.

What happens if my insurance denies Mounjaro coverage? If your insurance processes the claim and denies coverage (leaving you with a high copay), the Savings Card will still work and reduce your cost to $25. If your insurance has a hard formulary exclusion and refuses to process the claim at all, the Savings Card won't work, and you should apply for Lilly Cares as an uninsured patient.

Can I use GoodRx instead of the Mounjaro Savings Card? You can, but you shouldn't. GoodRx typically reduces Mounjaro cost to $950 to $1,000 per month. The Savings Card reduces it to $25. The Savings Card is always the better option for commercially insured patients. GoodRx makes sense only if you're paying cash and don't qualify for Lilly Cares.

How do I prove my income for Lilly Cares if I'm unemployed? Complete the zero-income affidavit included in the application packet. You'll also need to write a brief letter explaining how you're supporting yourself financially (savings, family support, etc.). Lilly Cares accepts zero-income applications as long as the affidavit is properly completed.

Is compounded tirzepatide the same as Mounjaro? Compounded tirzepatide contains the same active ingredient (tirzepatide) but is not FDA-approved and is not manufactured by Eli Lilly. It's prepared by compounding pharmacies in response to individual prescriptions. It's not interchangeable with Mounjaro and has not undergone the same safety and efficacy review process.

What if I make slightly more than the Lilly Cares income limit? You can still apply and explain extenuating circumstances in the application. Lilly Cares has discretion to approve patients who exceed the threshold by small margins if there's documented financial hardship (high medical expenses, recent job loss, etc.). Approval isn't guaranteed but is possible.

Does the Mounjaro Savings Card cover the full year? The card covers up to 12 prescription fills per calendar year with a maximum benefit of $12,500. For most patients on monthly dosing, that's 12 months of coverage. The card is currently valid through December 31, 2026, and Lilly typically extends it year by year.

Can I switch from brand-name Mounjaro to compounded tirzepatide? Yes. You'll need a new prescription from your provider specifying compounded tirzepatide. The dosing is the same, but the product is different, so a new prescription is required. Most providers will write the new prescription during a routine follow-up visit.

What should I do if the pharmacy says the Savings Card isn't working? Call Mounjaro support at 833-807-6706 immediately while you're still at the pharmacy. They will conference-call the pharmacy and troubleshoot in real-time. The most common issue is the pharmacy entering the card as primary payer instead of secondary, which support can correct.

Do I need prior authorization for Mounjaro if I'm using the Savings Card? That depends on your insurance. The Savings Card doesn't bypass prior authorization requirements. If your insurance requires PA, you still need to complete that process. The Savings Card only reduces your out-of-pocket cost after the claim is approved and processed.

How often do I need to reapply for Lilly Cares? Every 12 months. Lilly Cares will send a renewal notice 60 days before your approval expires. You'll need to submit updated income documentation and a current prescription. The renewal process is faster than the initial application, typically 5 to 7 business days.

Sources

1. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
2. Rosenstock J et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1). Diabetes Care. 2021.
3. Eli Lilly and Company. Mounjaro Prescribing Information. 2024.
4. U.S. Department of Health and Human Services. Federal Poverty Guidelines. 2026.
5. Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit Manual. 2025.
6. Office of Inspector General, HHS. Fraud and Abuse; Safe Harbor for Co-Pay Assistance Programs. Federal Register. 2020.
7. American Society of Health-System Pharmacists. Drug Shortages Statistics. 2026.
8. National Association of Boards of Pharmacy. Compounding Pharmacy Regulations. 2025.
9. Food and Drug Administration. Drug Shortages Database (Tirzepatide). Updated April 2026.
10. Medicare Rights Center. Guide to Medicare Part D Low-Income Subsidy. 2026.
11. National Conference of State Legislatures. State Pharmaceutical Assistance Programs. 2025.
12. Lilly Cares Foundation. Patient Assistance Program Guidelines. 2026.
13. GoodRx Research Team. GLP-1 Medication Pricing Analysis. 2026.
14. Kaiser Family Foundation. Employer Health Benefits Survey. 2025.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Medicare and Medicaid are registered trademarks of the U.S. Department of Health and Human Services. GoodRx is a registered trademark of GoodRx Holdings, Inc. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.